Cargando…

Therapeutic efficacy of azathioprine in addition to prednisone-based regimens as first-line chronic graft-versus-host disease treatment

Detalles Bibliográficos
Autores principales: Uhm, Jieun, Shin, Elizabeth, Michelis, Fotios V., Thyagu, Santhosh, Viswabandya, Auro, Lipton, Jeffrey H., Messner, Hans A., Kim, Dennis (Dong hwan)
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861088/
https://www.ncbi.nlm.nih.gov/pubmed/29247219
http://dx.doi.org/10.1038/s41409-017-0025-0
_version_ 1783308029386555392
author Uhm, Jieun
Shin, Elizabeth
Michelis, Fotios V.
Thyagu, Santhosh
Viswabandya, Auro
Lipton, Jeffrey H.
Messner, Hans A.
Kim, Dennis (Dong hwan)
author_facet Uhm, Jieun
Shin, Elizabeth
Michelis, Fotios V.
Thyagu, Santhosh
Viswabandya, Auro
Lipton, Jeffrey H.
Messner, Hans A.
Kim, Dennis (Dong hwan)
author_sort Uhm, Jieun
collection PubMed
description
format Online
Article
Text
id pubmed-5861088
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-58610882018-03-22 Therapeutic efficacy of azathioprine in addition to prednisone-based regimens as first-line chronic graft-versus-host disease treatment Uhm, Jieun Shin, Elizabeth Michelis, Fotios V. Thyagu, Santhosh Viswabandya, Auro Lipton, Jeffrey H. Messner, Hans A. Kim, Dennis (Dong hwan) Bone Marrow Transplant Correspondence Nature Publishing Group UK 2017-12-15 2018 /pmc/articles/PMC5861088/ /pubmed/29247219 http://dx.doi.org/10.1038/s41409-017-0025-0 Text en © The Author(s) 2017 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Correspondence
Uhm, Jieun
Shin, Elizabeth
Michelis, Fotios V.
Thyagu, Santhosh
Viswabandya, Auro
Lipton, Jeffrey H.
Messner, Hans A.
Kim, Dennis (Dong hwan)
Therapeutic efficacy of azathioprine in addition to prednisone-based regimens as first-line chronic graft-versus-host disease treatment
title Therapeutic efficacy of azathioprine in addition to prednisone-based regimens as first-line chronic graft-versus-host disease treatment
title_full Therapeutic efficacy of azathioprine in addition to prednisone-based regimens as first-line chronic graft-versus-host disease treatment
title_fullStr Therapeutic efficacy of azathioprine in addition to prednisone-based regimens as first-line chronic graft-versus-host disease treatment
title_full_unstemmed Therapeutic efficacy of azathioprine in addition to prednisone-based regimens as first-line chronic graft-versus-host disease treatment
title_short Therapeutic efficacy of azathioprine in addition to prednisone-based regimens as first-line chronic graft-versus-host disease treatment
title_sort therapeutic efficacy of azathioprine in addition to prednisone-based regimens as first-line chronic graft-versus-host disease treatment
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861088/
https://www.ncbi.nlm.nih.gov/pubmed/29247219
http://dx.doi.org/10.1038/s41409-017-0025-0
work_keys_str_mv AT uhmjieun therapeuticefficacyofazathioprineinadditiontoprednisonebasedregimensasfirstlinechronicgraftversushostdiseasetreatment
AT shinelizabeth therapeuticefficacyofazathioprineinadditiontoprednisonebasedregimensasfirstlinechronicgraftversushostdiseasetreatment
AT michelisfotiosv therapeuticefficacyofazathioprineinadditiontoprednisonebasedregimensasfirstlinechronicgraftversushostdiseasetreatment
AT thyagusanthosh therapeuticefficacyofazathioprineinadditiontoprednisonebasedregimensasfirstlinechronicgraftversushostdiseasetreatment
AT viswabandyaauro therapeuticefficacyofazathioprineinadditiontoprednisonebasedregimensasfirstlinechronicgraftversushostdiseasetreatment
AT liptonjeffreyh therapeuticefficacyofazathioprineinadditiontoprednisonebasedregimensasfirstlinechronicgraftversushostdiseasetreatment
AT messnerhansa therapeuticefficacyofazathioprineinadditiontoprednisonebasedregimensasfirstlinechronicgraftversushostdiseasetreatment
AT kimdennisdonghwan therapeuticefficacyofazathioprineinadditiontoprednisonebasedregimensasfirstlinechronicgraftversushostdiseasetreatment